Ligand Reports First Quarter 2026 Financial Results
Go back to Ligand Reports First Quarter 2026 Financial Results| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 304.26 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $304.26 | 52 Week High | $139.79 | |||
| Open | $304.26 | 52 Week Low | $82.07 | |||
| Day High | $304.26 | P/E | 707.58 | |||
| Day Low | $304.26 | EPS | $0.43 | |||
| Volume | 924 | |||||

